Mr. Iwanicki discusses the significance of Ariosa Diagnostics Inc. v. Sequenom Inc. in the Law360 article, “Patent Cases to Watch in 2016.”
In this case, a Federal Circuit panel invalidated a patent on Sequenom’s prenatal DNA test as patent-ineligible because it is directed to a natural phenomenon. The full Federal Circuit decided not to review the case. It is now expected to appealed to the Supreme Court.
Please click here to read the article.